Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index

Mediators of Inflammation

Volumn 12, Issue 2, 2003, Pages 123-125

  Di Lorenzo, Gabriele ^b   Gangemi, Sebastiano ^b   Merendino, Rosaria Alba ^b   Minciullo, Paola Lucia ^b   Cannavò, Serafina Paola ^b   Martinelli, Nicola ^a   Mansueto, Pasquale ^b   Rini, Giovanni Battista ^b   Corrocher, Roberto ^a   Pacor, Maria Luisa ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE

Author keywords

Atopic dermatitis; SCORAD; Serum sCD30

Indexed keywords

CD30 ANTIGEN; SOLUBLE CD30 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; MALE; PRICK TEST; PRIORITY JOURNAL; SCORING ATOPIC DERMATITIS INDEX; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS, CD30; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

MARTES PENNANTI;

EID: 10744232954     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/0962935031000097736     Document Type: Article

References (15)

1. D'Elios mm, Romagnani P, Scaletti C, et al. In vivo CD30 expression in human disease with predominant activation of Th2-like T cells. J Leukoc Biol 1997; 61: 539-544.
2. Gerli R, Lunardi C, Vinante F, Bistoni O; Pizzolo G, Pitzalis C. Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol 2001; 22: 72-77.
3. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999; 104: S99-S108.
4. Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992; 185: 88-92.
5. Sanchez-Guerrero I, Albaladejo MD, Garcia-Alonso AM, Muro M, Hernandez J, Alvarez MR. Solubile CD23 (sCD23) serum levels and lymphocyte subpopulations in asthma. Allergy 1994; 49: 587-592.
6. Trautmann A, Akdis M, Broker EB, Blaser K, Akdis CA. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. Trends Immunol 2001; 22: 530-532.
7. Kagi MK, Wuthrich B, Montano E, Barandun J, Blaser K, Walker C. Differential cytokine profiles in peripheral blood lymphocytes supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994; 103: 332-340.
8. Jung T, Witzak K, Dieckhoff K, Zachmann K, Heidrich S, Aversa G, Neumann C. IFN-gamma is only partially restored by co-stimulation with IL-12, Il-2, Il-15, IL-18 or engagement of CD28. Clin Exp Allergy 1999; 29: 207-216.
9. Caproni M, Salvatore E, Cardinali C, Brazzini B, Fabbri P. Solubile CD30 and cyclosporine in severe atopic dermatitis. Int Arch Allergy Immunol 2000; 12: 324-328.
10. Higashi N, Bang K, Gesser B, Lund M, Thestrup-Pedersen K. Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol 2001; 81: 3-7.
11. Tanaka Y. Pathogenesis and guidelines for therapy of atopic dermatitis. Nippon Rinsho 2001; 59: 1219-1227.
12. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the European Task Force on atopic dermatitis. Dermatology 1993; 186: 23-31.
13. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870-876.
14. Grewe M, Gyufko K, Schopf E, Krutman J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343: 25-26.
15. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154: 1956-1963.